Please use this identifier to cite or link to this item: https://doi.org/10.1038/bmt.2013.104
DC FieldValue
dc.titleTowards a global system of vigilance and surveillance in unrelated donors of haematopoietic progenitor cells for transplantation
dc.contributor.authorShaw, B.E.
dc.contributor.authorChapman, J.
dc.contributor.authorFechter, M.
dc.contributor.authorFoeken, L.
dc.contributor.authorGreinix, H.
dc.contributor.authorHwang, W.
dc.contributor.authorPhillips-Johnson, L.
dc.contributor.authorKorhonen, M.
dc.contributor.authorLindberg, B.
dc.contributor.authorNavarro, W.H.
dc.contributor.authorSzer, J.
dc.date.accessioned2016-06-01T10:27:09Z
dc.date.available2016-06-01T10:27:09Z
dc.date.issued2013-12
dc.identifier.citationShaw, B.E., Chapman, J., Fechter, M., Foeken, L., Greinix, H., Hwang, W., Phillips-Johnson, L., Korhonen, M., Lindberg, B., Navarro, W.H., Szer, J. (2013-12). Towards a global system of vigilance and surveillance in unrelated donors of haematopoietic progenitor cells for transplantation. Bone Marrow Transplantation 48 (12) : 1506-1509. ScholarBank@NUS Repository. https://doi.org/10.1038/bmt.2013.104
dc.identifier.issn02683369
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/124720
dc.description.abstractSafety of living donors is critical to the success of blood, tissue and organ transplantation. Structured and robust vigilance and surveillance systems exist as part of some national entities, but historically no global systems are in place to ensure conformity, harmonisation and the recognition of rare adverse events (AEs). The World Health Assembly has recently resolved to require AE/reaction (AE/R) reporting both nationally and globally. The World Marrow Donor Association (WMDA) is an international organisation promoting the safety of unrelated donors and progenitor cell products for use in haematopoietic progenitor cell (HPC) transplantation. To address this issue, we established a system for collecting, collating, analysing, distributing and reacting to serious adverse events and reactions (SAE/R) in unrelated HPC donors. The WMDA successfully instituted this reporting system with 203 SAE/R reported in 2011. The committee generated two rapid reports, reacting to specific SAE/R, resulting in practice changing policies. The system has a robust governance structure, formal feedback to the WMDA membership and transparent information flows to other agencies, specialist physicians and transplant programs and the general public. © 2013 Macmillan Publishers Limited All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1038/bmt.2013.104
dc.sourceScopus
dc.subjecthaematopoietic cell transplantation
dc.subjectserious adverse event
dc.subjectserious adverse reaction
dc.subjectunrelated donor
dc.subjectvigilance and surveillance
dc.typeArticle
dc.contributor.departmentDUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
dc.description.doi10.1038/bmt.2013.104
dc.description.sourcetitleBone Marrow Transplantation
dc.description.volume48
dc.description.issue12
dc.description.page1506-1509
dc.description.codenBMTRE
dc.identifier.isiut000328051000003
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.